» Articles » PMID: 37529038

Transition Practice for Primary Immunodeficiency Diseases in Southeast Asia: a Regional Survey

Abstract

Introduction: With increased diagnostic capabilities and treatment modalities in the field of primary immunodeficiencies (PID), many pediatric patients survive beyond childhood and experience a change of care to the adult-oriented healthcare system. Unfortunately, the transition pathways for PID are less clearly defined, resulting in deterioration of quality of care in adulthood. Hence, this is the first regional study to address PID clinicians' opinions on practices and challenges of transition care in 7 Southeast Asia (SEA) countries.

Methods: We adopted a cross-sectional study design through an online survey platform to enquire opinions of transition practices from expert representatives in 7 SEA countries.

Results: Regionally, 3 out 7 countries reported having no practice of transition care. Among cited challenges were reluctant adaptation by patients and caregivers to unfamiliarized adult healthcare systems, inadequate ratio of adult immunologists to patients and lack of facilities for transfer.

Discussion And Conclusion: Our study provides evidence to advocate policy makers on the importance of standardized integration of transition practice towards betterment of transiting PID patients into adulthood.

Citing Articles

Recommendations for Transitioning Young People with Primary Immunodeficiency Disorders and Autoinflammatory Diseases to Adult Care.

Israni M, Alderson E, Mahlaoui N, Obici L, Rossi-Semerano L, Lachmann H J Clin Immunol. 2024; 45(1):57.

PMID: 39690292 PMC: 11652586. DOI: 10.1007/s10875-024-01838-y.


Newborn screening for severe combined immunodeficiency in Malaysia: current status, challenges and progress.

Chang W, Mohd Noh L, Abdul Latiff A, Woo K, Ismail I, Hamid I Front Immunol. 2024; 15:1456769.

PMID: 39416794 PMC: 11479922. DOI: 10.3389/fimmu.2024.1456769.


Paving the way in implementation of SCID newborn screening in developing nations: feasibility study and strategies to move forward in Malaysia.

Kumarasamy G, Khairiz K, Chang W, Aye T, Ali A Front Immunol. 2024; 15:1400247.

PMID: 38983864 PMC: 11231083. DOI: 10.3389/fimmu.2024.1400247.


Knowledge, awareness, and perception on genetic testing for primary immunodeficiency disease among parents in Malaysia: a qualitative study.

Ahmad Azahari A, Hakim Zada F, Ismail I, Hamid I, Lim B, Ismail N Front Immunol. 2024; 14:1308305.

PMID: 38283358 PMC: 10811462. DOI: 10.3389/fimmu.2023.1308305.


Transition of care in inborn errors of immunity.

Tadros S, Burns S Curr Opin Allergy Clin Immunol. 2023; 23(6):455-460.

PMID: 37797181 PMC: 10621636. DOI: 10.1097/ACI.0000000000000948.

References
1.
Tangye S, Al-Herz W, Bousfiha A, Chatila T, Cunningham-Rundles C, Etzioni A . Human Inborn Errors of Immunity: 2019 Update on the Classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol. 2020; 40(1):24-64. PMC: 7082301. DOI: 10.1007/s10875-019-00737-x. View

2.
Israni M, Nicholson B, Mahlaoui N, Obici L, Rossi-Semerano L, Lachmann H . Current Transition Practice for Primary Immunodeficiencies and Autoinflammatory Diseases in Europe: a RITA-ERN Survey. J Clin Immunol. 2022; 43(1):206-216. PMC: 9840587. DOI: 10.1007/s10875-022-01345-y. View

3.
Chan C, Mahlaoui N, Sanchez Ramon S, Pergent M, Solis L, Prevot J . Primary immunodeficiencies (PID) Life Index in Southeast Asia: A comparative analysis of PID Principles of Care (PoC). Front Immunol. 2023; 14:1151335. PMC: 10097921. DOI: 10.3389/fimmu.2023.1151335. View

4.
Meyts I, Bousfiha A, Duff C, Singh S, Lau Y, Condino-Neto A . Primary Immunodeficiencies: A Decade of Progress and a Promising Future. Front Immunol. 2021; 11:625753. PMC: 7935502. DOI: 10.3389/fimmu.2020.625753. View

5.
Cirillo E, Giardino G, Ricci S, Moschese V, Lougaris V, Conti F . Consensus of the Italian Primary Immunodeficiency Network on transition management from pediatric to adult care in patients affected with childhood-onset inborn errors of immunity. J Allergy Clin Immunol. 2020; 146(5):967-983. DOI: 10.1016/j.jaci.2020.08.010. View